共 45 条
- [21] One-year results of canakinumab (ACZ885), a fully human anti-IL-1beta monoclonal antibody in patients with cryopyrin-associated periodic fever syndrome (CAPS)SWISS MEDICAL WEEKLY, 2009, 139 (31-32) : 4S - 4SKuemmerle-Deschner, J.Lachmann, H. J.Kone-Paut, I.Leslie, K.Hachulla, E.Quartier, P.Krammer, G.Patel, N.Lheritier, K.Preiss, R.Hawkins, P. N.
- [22] Two cases of atypical hemolytic uremic syndrome due to anti-factor H autoantibodies successfully treated by plasma exchange, corticosteroids and mizoribineIMMUNOBIOLOGY, 2016, 221 (10) : 1145 - 1145Sawai, ToshihiroOkuda, YusukeMasuda, ToshikiSakai, TomoyukiMaeda, ToshinagaTortajada, AgustinRodriguez de Cordoba, Santiago
- [23] Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiologyCURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (03) : 83 - 86Soudet, SimonFajgenbaum, DavidDelattre, ClaireForestier, AlexandraHachulla, EricHatron, Pierre YvesLaunay, Davidterriou, Louis
- [24] First reported cases with Xia-Gibbs syndrome from India harboring novel variants in AHDC1AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2022, 188 (08) : 2501 - 2504Danda, SumitaDatar, ChaitanyaKher, ArchanaDeshpande, TanmayThomas, Maya MaryOommen, Samuel P.
- [25] CANAKINUMAB (ACZ885), A NEW IL-1BETA BLOCKING MONOCLONAL ANTIBODY PROVIDES SUSTAINED REMISSION IN CHILDREN WITH CRYOPYRIN ASSOCIATED PERIODIC FEVER SYNDROME (CAPS)ACTA PAEDIATRICA, 2009, 98 : 172 - 172Kuemmerle-Deschner, J.Blank, N.Roesler, J.Gramlich, K.Jimenez, S.Felix, S. D.Tannenbaum, S.Chakraborty, A.Rordorf, C.Ramos, E.
- [26] Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding studyBMC MUSCULOSKELETAL DISORDERS, 2011, 12Alten, RiekeGomez-Reino, JuanDurez, PatrickBeaulieu, AndreSebba, AnthonyKrammer, GerhardPreiss, RalphArulmani, UdayasankarWidmer, AlbertGitton, XavierKellner, Herbert
- [27] LONG TERM FOLLOW-UP OF QUALITY OF LIFE IN PATIENTS WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROME TREATED BY CANAKINUMAB, AN ANTI INTERLEUKINE-1B MONOCLONAL ANTIBODYANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 331 - 331Marsaud, C.Marie, I.Kone-Paut, I.
- [28] EFFICACY OF CANAKINUMAB (ACZ885), A FULLY HUMAN ANTI-INTERLEUKIN (IL)-1BETA MONOCLONAL ANTIBODY, IN THE PREVENTION OF FLARES IN GOUT PATIENTS INITIATING ALLOPURINOL THERAPYJOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (04) : 710 - 711Schlesinger, N.Rudolph, L.Lin, H.De Meulemeester, M.Nasonov, E. L.Rovensky, J.Mysler, E. F.Arulmani, U.Krammer, G.Balfour, A.Richard, D.Sallstig, P.So, A. K.
- [29] Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 PembrolizumabJCO PRECISION ONCOLOGY, 2023, 7Djerroudi, LounesMasliah-Planchon, JulienBrisse, Herve J.El Zein, SophieHelfre, SylvieTzanis, DimitriHamzaoui, NadimBonnet, ClementLaurence, ValerieBonvalot, SylvieWatson, Sarah
- [30] Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding studyBMC Musculoskeletal Disorders, 12Rieke AltenJuan Gomez-ReinoPatrick DurezAndre BeaulieuAnthony SebbaGerhard KrammerRalph PreissUdayasankar ArulmaniAlbert WidmerXavier GittonHerbert Kellner